What Is Dronedarone Used For?
Dronedarone is licensed to treat certain irregular heart rhythms known as atrial flutter and atrial fibrillation. It is not approved for people currently in atrial fibrillation or atrial flutter; instead, it is used to help people stay in "normal sinus rhythm." Healthcare providers may also sometimes recommend off-label uses for dronedarone, such as for the treatment of other types of irregular heart rhythms.
Dronedarone (Multaq®) is a prescription arrhythmia medicine approved for the treatment of the following medical conditions:
- Atrial fibrillation
- Atrial flutter.
Specifically, it is approved to reduce the risk of heart-related hospitalization in people who meet all of the following criteria:
- Have atrial fibrillation or atrial flutter
- Have other cardiovascular risk factors, such as:
- Have had a recent episode of atrial fibrillation or atrial flutter (within the past six months)
- Currently have a normal heart rhythm (or are about to be converted to a normal heart rhythm).
Dronedarone is not approved for people currently in atrial fibrillation or atrial flutter. Instead, it is used to help people stay in "normal sinus rhythm."
Dronedarone must not be used in people whose heart rhythm cannot be converted to normal ("permanent atrial fibrillation"). Studies have shown that dronedarone doubles the risk of heart failure and heart-related death and increases the risk of stroke in people with permanent atrial fibrillation. Your healthcare provider should check your heart rhythm every three months to make sure your atrial fibrillation has not returned.